Clinical Trial Update: A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee [Phase 2]

View source ↗

Summary

Completed Phase 2 trial evaluating the safety and effectiveness of orally administered CR845 in patients with osteoarthritis of the hip or knee.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• CR845 (difelikefalin)

Snippet

Sponsor: Cara Therapeutics, Inc. | Conditions: Osteoarthritis | Phase 2 | Status: COMPLETED